pindolol and Glaucoma
pindolol has been researched along with Glaucoma in 8 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pindolol, a strong beta-adrenergic blocking agent, instilled into the conjunctival sac of normal and glaucomatous eyes, produced a significant drop in intraocular pressure." | 9.04 | Effect of pindolol on intraocular pressure. ( Bonomi, I; Steindler, P, 1975) |
| "The dye sensitized photooxidation in water (pH 6), of the pharmaceutical topical antiglaucoma drugs, Timolol and Pindolol, which act as beta-adrenergic receptor antagonists, were studied by means of static and time-resolved spectroscopic methods and polarographic determinations." | 7.71 | Singlet molecular oxygen generation and quenching by the antiglaucoma ophthalmic drugs, Timolol and Pindolol. ( Allegretti, P; Bertolotti, SG; Criado, S; Furlong, J; García, NA; La Falce, E; Mártire, D, 2002) |
| "Pindolol, a strong beta-adrenergic blocking agent, instilled into the conjunctival sac of normal and glaucomatous eyes, produced a significant drop in intraocular pressure." | 5.04 | Effect of pindolol on intraocular pressure. ( Bonomi, I; Steindler, P, 1975) |
| "The dye sensitized photooxidation in water (pH 6), of the pharmaceutical topical antiglaucoma drugs, Timolol and Pindolol, which act as beta-adrenergic receptor antagonists, were studied by means of static and time-resolved spectroscopic methods and polarographic determinations." | 3.71 | Singlet molecular oxygen generation and quenching by the antiglaucoma ophthalmic drugs, Timolol and Pindolol. ( Allegretti, P; Bertolotti, SG; Criado, S; Furlong, J; García, NA; La Falce, E; Mártire, D, 2002) |
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Criado, S | 1 |
| Mártire, D | 1 |
| Allegretti, P | 1 |
| Furlong, J | 1 |
| Bertolotti, SG | 1 |
| La Falce, E | 1 |
| García, NA | 1 |
| Koch-Weser, J | 1 |
| Frishman, WH | 1 |
| Bleckmann, H | 1 |
| Dorow, P | 1 |
| Bonomi, I | 1 |
| Steindler, P | 1 |
| Schnarr, KD | 1 |
| Schell, E | 1 |
| Görlich, W | 2 |
| Lang, E | 1 |
Reviews
1 review available for pindolol and Glaucoma
| Article | Year |
|---|---|
beta-Adrenoceptor antagonists: new drugs and new indications.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Glaucoma; Humans; Hypertension; Kinetics; Me | 1981 |
Trials
2 trials available for pindolol and Glaucoma
| Article | Year |
|---|---|
[Indications and contraindications of beta blockaders in the treatment of glaucoma].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Airway Resistance; Female; Glaucoma; Humans; Intraocular P | 1984 |
Effect of pindolol on intraocular pressure.
Topics: Adult; Aged; Aqueous Humor; Clinical Trials as Topic; Female; Glaucoma; Humans; Intraocular Pressure | 1975 |
Other Studies
5 other studies available for pindolol and Glaucoma
| Article | Year |
|---|---|
Singlet molecular oxygen generation and quenching by the antiglaucoma ophthalmic drugs, Timolol and Pindolol.
Topics: Adrenergic beta-Antagonists; Animals; Glaucoma; Humans; Kinetics; Light; Photolysis; Photosensitizin | 2002 |
Beta-blockers in the treatment of chronic simple glaucoma.
Topics: Adrenergic beta-Antagonists; Glaucoma; Humans; Pindolol; Practolol; Propranolol | 1976 |
[Comparative multicenter study of carteolol eyedrops with other beta blockers in 768 patients under normal conditions].
Topics: Adrenergic beta-Antagonists; Carteolol; Drug Evaluation; Glaucoma; Humans; Intraocular Pressure; Met | 1988 |
[Pindolol eyedrops: does ISA provide more cardiac safety?].
Topics: Female; Glaucoma; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Ophthalmic Solution | 1986 |
[Is the use of beta receptor blockers in variously strong concentrations in the treatment of glaucoma sensible?].
Topics: Dose-Response Relationship, Drug; Glaucoma; Humans; Intraocular Pressure; Pindolol; Risk; Timolol | 1985 |